Scotts Miracle-Gro profit falls 60% but beats estimates, as revenue falls short
Scotts Miracle-Gro Co. (SMG) said Wednesday its fiscal second-quarter profit dropped by 60% to $109.4 million, or $1.94 a share, from $276.5 million, or $4.94 a share, in the year-ago quarter. Adjusted profit in the latest quarter totaled $3.78 a share, ahead of the analyst estimate of $3.47 a share, according to data from FactSet. Revenue at the fertilizer and hydroponic growing products maker fell 9% to $1.53 billion, below the estimate of $1.61 billion. The company plans to provide an update on business results and outlook in early June. "After a slow start through March, partly driven by extreme weather in the West, the U.S. consumer business saw improved consumer demand entering May," the company said. Sales at its Hawthorne growing equipment unit aimed at the cannabis market fell 54% to $93 million, "reflecting the continued challenges in the hydroponic industry." Scotts Miracle-Gro said its project springboard project will generate $200 million in cost savings. Scotts Miracle-Gro stock is up 42.7% in 2023 compared to a 15.4% increase by the Nasdaq .
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-03-23 0750ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Markets Brief: Is It Really a Surprising Quarter for Earnings?
-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom